Cat. #151678
PEA1 Cell Line
Cat. #: 151678
Organism: Human
Tissue: Ovary
Model: Tumour line
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Simon Langdon
Institute: Cancer Research UK Edinburgh Centre
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: PEA1 Cell Line
- Cancer type: Ovarian cancer
- Cancers detailed: Adenocarcinoma
- Research fields: Cancer;Drug development
- Organism: Human
- Tissue: Ovary
- Growth properties: Adherent
- Model: Tumour line
- Description: The PEA1 cell line is one of nine from the PE ovarian adenocarcinoma panel (derived from 4 patients at varying stages of ovarian cancer, isolated from various malignant sites, and at various treatment stages) which provides a model system for research into the mechanism of oestrogen action on ovarian adenocarcinoma tumour cells, and for the study of efficacy and toxicity of oestrogen protagonists. It is an adherent cell line derived from a malignant effusion from the pleural cavity of a patient with a poorly differentiated adenocarcinoma. This cell line was collected prior to treatment with cisplatin and prednimustine. PEA1 exhibits poor growth in semi-solid medium (agar) and is from the same patient as the PEA2 cell line.
- Cellosaurus id: CVCL_2682
Handling
- Format: Frozen
- Growth medium: RPMI 1640 + 2mM Glutamine + 2mM Sodium Pyruvate + 10% Foetal Bovine Serum (FBS).
- Shipping conditions: Dry ice
- Subculture routine: Split sub-confluent cultures (70-80%) 1:4 to 1:10 seeding at 2- 3 x 10^4 cells/cm²
Related Tools
- Related tools: PEO1 Cell Line ; PEO4 Cell Line ; PEO6 Cell Line ; PEA2 Cell Line ; PEO14 Cell Line ; PEO16 Cell Line ; PEO23 Cell Line ; PEO1-CDDP Cell Line ; TO14 Cell Line
References
- Matassa et al. 2016. Cell Death Differ. :. PMID: 27206315.
- Beaufort et al. 2014. PLoS One. 9(9):e103988. PMID: 25230021.
- Langdon et al. 1990. Br J Cancer. 62(2):213-6. PMID: 2386737.
- Langdon et al. 1988. Cancer Res. 48(21):6166-72. PMID: 3167863.


![Anti-CAR Whitlow Linker [1C3C3]](https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-300x322.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-280x300.jpg 280w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-954x1024.jpg 954w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-768x824.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 1193w)


